Xu L - Search Results

1

IGFALS suppresses hepatocellular carcinoma progression by stabilizing PPAR-γ.

Xu L, Xiong L, Chen Y, Chen J, Liu X, Xu Y, Shen Y, Wang S, Yu S, Xu X. Xu L, et al. Among authors: xu x, xu y. Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113414. doi: 10.1016/j.intimp.2024.113414. Epub 2024 Oct 29. Int Immunopharmacol. 2024. PMID: 39471694

2

CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis.

Xu L, Long H, Zhou B, Jiang H, Cai M. Xu L, et al. Curr Eye Res. 2021 Nov;46(11):1751-1761. doi: 10.1080/02713683.2021.1927110. Epub 2021 May 14. Curr Eye Res. 2021. PMID: 33988065

3

miR-486-5p Restrains Extracellular Matrix Production and Oxidative Damage in Human Trabecular Meshwork Cells by Targeting TGF-β/SMAD2 Pathway.

Xu L, Zhang Y, Long H, Zhou B, Jiang H. Xu L, et al. J Ophthalmol. 2022 Feb 23;2022:3584192. doi: 10.1155/2022/3584192. eCollection 2022. J Ophthalmol. 2022. PMID: 35251709 Free PMC article.

4

Development and Validation of KCPREDICT: A Deep Learning Model for Early Detection of Coronary Artery Lesions in Kawasaki Disease Patients.

Yang L, Shen X, Liu Y, Chen J, Zou Y, Xu L, Ji W, Zhang Y, Liu T, Cao Q. Yang L, et al. Among authors: xu l. Pediatr Cardiol. 2025 Jan 18. doi: 10.1007/s00246-024-03762-9. Online ahead of print. Pediatr Cardiol. 2025. PMID: 39825907

5

Construction of a Vero cell line expression human KREMEN1 for the development of CVA6 vaccines.

Zhang D, Zou Y, Wu J, Xu L, Ke Z, Wu Y, Zhou Z, Fang M, Chen L, Xu H, Chu J, Xia N, Zhu R, Cheng T. Zhang D, et al. Among authors: xu l. Virol J. 2025 Jan 17;22(1):12. doi: 10.1186/s12985-024-02618-1. Virol J. 2025. PMID: 39825444

6

Efficacy of concurrent balloon eustachian tuboplasty in the treatment of chronic otitis media with effusion in children with tonsil and adenoid hypertrophy.

Ma J, Kang Z, Xu L, Ai P, Zhang Q, Wang L. Ma J, et al. Among authors: xu l. Eur Arch Otorhinolaryngol. 2025 Jan 17. doi: 10.1007/s00405-024-09158-y. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 39825201

7

Physical and emotional abuse with internet addiction and anxiety as a mediator and physical activity as a moderator.

Peng J, Liu Y, Wang X, Yi Z, Xu L, Zhang F. Peng J, et al. Among authors: xu l. Sci Rep. 2025 Jan 17;15(1):2305. doi: 10.1038/s41598-025-85943-x. Sci Rep. 2025. PMID: 39824886

8

Enhancing Catalytic Removal of Autoexhaust Soot Particles via the Modulation of Interfacial Oxygen Vacancies in Cu/CeO₂ Catalysts.

Li Y, Qin T, Xu L, Ma Y, Guo H, Xiong J, Zhang P, Zhao Z, Liu X, Liu Y, Zou J, Chen L, Wei Y. Li Y, et al. Among authors: xu l. Environ Sci Technol. 2025 Jan 17. doi: 10.1021/acs.est.4c12325. Online ahead of print. Environ Sci Technol. 2025. PMID: 39824766

9

Manganese Intercalation Enabling High-Performance Aqueous Fe-VO₂ Batteries.

Luo S, Liang S, Cui J, Guo Y, Yuan B, Xu L, Zheng R, Li J, Yang W, Luo Y. Luo S, et al. Among authors: xu l. ACS Appl Mater Interfaces. 2025 Jan 17. doi: 10.1021/acsami.4c17042. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39824750

10

TGR5 attenuates DOCA-salt hypertension through regulating histone H3K4 methylation of ENaC in the kidney.

Xu L, Wu X, Long L, Li S, Huang M, Li M, Feng P, Levi M, Chen W, Wang L, Li C, Wang W. Xu L, et al. Metabolism. 2025 Jan 15:156133. doi: 10.1016/j.metabol.2025.156133. Online ahead of print. Metabolism. 2025. PMID: 39824478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,037 results

Search Page

Filters